Lactaid vs IBM

Side-by-side comparison of AI visibility scores, market position, and capabilities

IBM leads in AI visibility (80 vs 22)
Lactaid logo

Lactaid

EmergingConsumer Food & Beverage

Milk

Kenvue-owned lactose-free dairy brand with enzyme-treated real milk and ice cream; leading lactase-treated dairy competing with Fairlife and plant-based alternatives for lactose-intolerant consumers.

AI VisibilityBeta
Overall Score
D22
Category Rank
#4 of 5
AI Consensus
67%
Trend
up
Per Platform
ChatGPT
28
Perplexity
23
Gemini
20

About

Lactaid is the leading lactose-free dairy brand, producing milk, ice cream, cottage cheese, and cream products that are treated with lactase enzyme to pre-digest the lactose — allowing the estimated 36% of Americans who are lactose intolerant to enjoy real dairy products without gastrointestinal symptoms. Lactaid is owned by McNeil Nutritionals, a subsidiary of Johnson & Johnson (NYSE: JNJ), though J&J has divested various consumer health assets over the years; the Lactaid brand is now part of the consumer health spinoff Kenvue (NYSE: KVUE).\n\nLactaid's products are made with real cow's milk that undergoes lactase enzyme treatment to break down lactose into simpler sugars (glucose and galactose) that lactose-intolerant individuals can digest without discomfort. The resulting products taste like regular dairy (the additional simple sugars may make the milk slightly sweeter) but are tolerated by those who lack sufficient lactase enzyme production. The Lactaid milk line includes whole, 2%, 1%, fat-free, and calcium-enriched varieties, with the ice cream line as an important premium revenue driver.\n\nIn 2025, Lactaid competes with Fairlife (Coca-Cola, ultra-filtered lactose-free milk), private label lactose-free milk from Horizon Organic (Danone), and plant-based milk alternatives (oat milk, almond milk) that lactose-intolerant consumers may choose instead. Lactaid's brand positioning as real dairy (unlike plant-based alternatives) and its established retail distribution give it a defensible position among lactose-intolerant consumers who prefer dairy taste and nutrition. Kenvue's ownership (post-J&J consumer health spinoff in 2023) provides a dedicated consumer health focus. The 2025 strategy focuses on growing the premium ice cream segment, maintaining retail distribution leadership, and reinforcing the "real dairy, no discomfort" positioning that differentiates Lactaid from both plant-based alternatives and generic lactase supplements.

Full profile
IBM logo

IBM

LeaderEnterprise Software

General

Armonk NY hybrid cloud and enterprise AI (NYSE: IBM) at $62.8B revenue; $6B+ generative AI bookings, record $12.7B free cash flow 2024, DataStax acquisition for watsonx vector database competing with Microsoft Azure for enterprise AI.

AI VisibilityBeta
Overall Score
A80
Category Rank
#56 of 1158
AI Consensus
67%
Trend
up
Per Platform
ChatGPT
74
Perplexity
71
Gemini
84

About

International Business Machines Corporation (IBM) is an Armonk, New York-based global technology and consulting company — publicly traded on the New York Stock Exchange (NYSE: IBM) as an S&P 500 component — providing hybrid cloud infrastructure, artificial intelligence software, and enterprise IT consulting through approximately 270,300 employees in 170 countries with $62.8 billion in annual revenue. Founded on June 16, 1911, as Computing-Tabulating-Recording Company through a merger orchestrated by financier Charles Ranlett Flint, renamed IBM in 1924 under Thomas Watson Sr., IBM has undergone multiple strategic transformations over its 110+ year history: building the System/360 mainframe platform (1964), launching the IBM PC (1981), selling the PC division to Lenovo (2005, $1.75B), and completing the $34 billion Red Hat acquisition (2019) that repositioned IBM as a hybrid cloud platform company. CEO Arvind Krishna (appointed April 2020) has focused IBM's strategy on three areas: hybrid cloud (powered by Red Hat OpenShift, the enterprise Kubernetes platform), AI (the watsonx platform for enterprise AI model development and deployment), and enterprise consulting. Under Krishna, IBM recorded $12.7 billion in free cash flow in 2024 (a company record), surpassed $6 billion in generative AI bookings since June 2023, and saw the stock price double — trading at all-time highs through 2024-2025. IBM announced the DataStax acquisition in 2025 to deepen watsonx's data layer with AstraDB (vector database for AI applications), DataStax Enterprise (Apache Cassandra), and Langflow (low-code AI agent development).

Full profile

AI Visibility Head-to-Head

22
Overall Score
80
#4
Category Rank
#56
67
AI Consensus
67
up
Trend
up
28
ChatGPT
74
23
Perplexity
71
20
Gemini
84
13
Claude
74
21
Grok
81

Capabilities & Ecosystem

Capabilities

Only Lactaid
Milk
IBM is classified as company.

Track AI Visibility in Real Time

Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.